Low‐density lipoproteins increase intracellular calcium in aequorin‐loaded platelets
- 10 October 1988
- journal article
- Published by Wiley in FEBS Letters
- Vol. 238 (2) , 357-360
- https://doi.org/10.1016/0014-5793(88)80512-x
Abstract
Low-density lipoproteins activate isolated human platelets. The mechanism of this activation is unknown, but may involve increased phosphoinositide turnover. We have examined the effect of low-density lipoproteins on intracellular calcium concentrations in platelets loaded with the photoprotein aequorin. The lipoproteins induced concentration-dependent increases in intracellular calcium, associated with shape change and aggregation. These responses could be partially inhibited by the removal of extracellular calcium and by pre-incubation with acetylsalicylic acid. They were also antagonised by agents which increase cellular concentrations of cyclic adenosine and guanosine monophosphates. It is not clear whether the platelet-lipoprotein interaction involves a 'classical' lipoprotein receptor.Keywords
This publication has 19 references indexed in Scilit:
- Platelet activation by plasma lipoproteinsProgress in Cardiovascular Diseases, 1987
- Intracellular mechanisms in the activation of human platelets by low-density lipoproteinsBiochemical Journal, 1987
- The phosphoinositides exist in multiple metabolic pools in rabbit plateletsBiochemical Journal, 1986
- Inhibition of human platelet aggregation and cytoplasmic calcium response by calcium antagonists: studies with aequorin and quin2.Circulation Research, 1986
- Platelet low-density lipoprotein receptorsBiochemical Society Transactions, 1985
- Abnormal plasma lipoprotein composition in hypercholesterolaemic patients induces platelet activationEuropean Journal of Clinical Investigation, 1984
- The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclinBiochemical Journal, 1983
- Influence of plasma lipoproteins on platelet aggregation in a normal male population.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983
- HL 725, an extremely potent inhibitor of platelet phosphodiesterase and induced platelet aggregation in vitroLife Sciences, 1982
- Platelet Function in HyperlipoproteinemiaNew England Journal of Medicine, 1974